Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1623 1629
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18723254 | COMPOSITION FOR PROMOTING PLANT DISEASE RESISTANCE | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18839945 | METHODS FOR TREATING SUBJECTS WITH ABDOMINAL OBESITY HYPERTRIGLYCERIDEMIA AND/OR IMPAIRED GLUCOSE | Non-Final OA | NOVO NORDISK A/S |
| 18837928 | PYRAZOLOPYRIMIDINES, COMPOSITIONS COMPRISING THEM AND USES THEREOF | Non-Final OA | Novo Nordisk A/S |
| 18631941 | SYNERGISTIC DRUG COMBINATIONS TO TREAT CANCER | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18281826 | CORE-SHELL DYE, NEAR-INFRARED ABSORBING COMPOSITION INCLUDING THE SAME, AND NEAR-INFRARED ABSORBING FILM | Non-Final OA | SAMSUNG SDI CO., LTD. |
| 18846183 | TREATMENT OF BREAST CANCER WITH AMCENESTRANT | Non-Final OA | SANOFI |
| 18543287 | COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND AT LEAST ONE BOOSTER | Non-Final OA | L'OREAL |
| 18541121 | POTENTIATING THE TUMOR-SELECTIVE EFFECTS OF NQO1-BIOACTIVATABLE AGENT BY USE OF CMET INHIBITOR | Non-Final OA | The Trustees of Indiana University |
| 18849105 | DRUG FOR TREATING OR PREVENTING CHARCOT-MARIE-TOOTH DISEASE | Non-Final OA | Kyoto University |
| 18719695 | FUSED PYRROLIDINE PSYCHOPLASTOGENS AND USES THEREOF | Non-Final OA | Delix Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy